A Long-Term Safety Study of ALKS 5461
NCT02141399
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1485
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
ALKS 5461
Sponsor
Alkermes, Inc.